Merck and Ablynx = 7 billion deal
Merck and Eisai = 5.7 billion deal
Bristol-Myers Squibb and Nektar Therapeutics = 3.6 billion deal
REPL. Replimune market cap of 2 billion, and in my opinion has got nothing close to what we have.
IMUGENE = what , imho IMU equals the most under valued stock on the ASX
The time is near to a massive re-rate , starting from this quarter and over the next 12 months is going to be so exciting.
Thats what my balls are telling me.
Merck and Ablynx = 7 billion dealMerck and Eisai = 5.7 billion...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.002(3.92%) |
Mkt cap ! $387.9M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.3¢ | 5.0¢ | $605.4K | 11.73M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 455000 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 1913821 | 7 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |